Carol PItzel Cruz

Carol PItzel Cruz

Knobbe Martens Olson & Bear LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

FDA Publishes "Purple Book" for Biosimilars

FDA Publishes "Purple Book" to Catalog Biologics, Interchangeable and Biosimilar Products - The US Food and Drug Administration (“FDA”) recently published its first “Lists of Licensed Biological Products with Reference...more

9/11/2014 - Biosimilars FDA Pharmaceutical Public Health Service Act

Northern District of California Interprets the Biosimilars Act and Limits Declaratory Relief for Biosimilar Manufacturer: What You...

In the first instance of a district court interpreting the patent litigation provisions of the Biologics Price Competition and Innovation Act (“Biosimilars Act”), Judge Maxine E. Chesney (N.D. Cal.) dismissed a declaratory...more

11/15/2013 - Biosimilars Drug Manufacturers FDA Patents Pharmaceutical Prescription Drugs

Biosimilars Webinar - July 23, 2013

On Tuesday, July 23, Knobbe Martens hosted a live webinar event covering "Preparing for Biosimilars: Key Points for Participating in the U.S. Regulatory Framework." Partners Eli Loots, Carol Pitzel Cruz, and Sheila Swaroop...more

7/26/2013 - Affordable Care Act America Invents Act Biosimilars BPCIA Ex Partes Reexamination FDA Healthcare Patent Reform Patents

U.S. Biosimilars - Red Flags for Patent Attorneys

On March 14, 2013, Knobbe Martens Partner Carol Pitzel Cruz presented at the 24th C5 Forum on Biotech Patenting 2013. This conference allows attendees to benchmark against the best practice strategies employed by the market...more

4/24/2013

4 Results
|
View per page
Page: of 1